Publications by Misti McCain - ePrints

Browsing publications by Misti McCain.

Newcastle Authors	Title	Year
Dr Kate Hallsworth Misti McCain Dr Morven Brown Dr Sam Orange Professor Helen Reeves et al.	Is home-based, virtually-delivered, group exercise feasible and acceptable for older patients with hepatocellular carcinoma? A non-randomised feasibility study (TELEX-Liver Cancer)	2024
Dr Jack Leslie Dr Jill Hunter Amy Collins Amelia Rushton Lauren Russell et al.	c-Rel–dependent Chk2 signaling regulates the DNA damage response limiting hepatocarcinogenesis	2023
Professor Helen Reeves Misti McCain	Discriminatory Changes in Circulating Metabolites as a Predictor of Hepatocellular Cancer in Patients with Metabolic (Dysfunction) Associated Fatty Liver Disease	2023
Dr Kate Hallsworth Dr Sam Orange Misti McCain Professor Helen Reeves	Feasibility of a home-based, virtually-delivered, group exercise intervention in older patients with liver cancer (TELEX-Liver Cancer)	2023
Bassier Zadran Daniel Wainwright Dr Yvonne Bury Dr Saimir Luli Rachel Howarth et al.	Impact of retrotransposon protein L1 ORF1p expression on oncogenic pathways in hepatocellular carcinoma: the role of cytoplasmic PIN1 upregulation	2023
Dr Daniel Geh Robyn Watson Gourab Sen Jeremy French John Hammond et al.	COVID-19 and liver cancer: Lost patients and larger tumours	2022
Dr Jack Leslie Erik Ramon Gil Kathryn Gilroy Dr Saimir Luli Maja Laszczewska et al.	CXCR2 inhibition enables NASH-HCC immunotherapy	2022
Dr Steven Masson Misti McCain Professor Helen Reeves	Restoring cellular magnesium balance through Cyclin M4 protects against acetaminophen-induced liver damage	2022
Dr Marco Zaki Dr Sari Alhasan Dr Ruchi Shukla Misti McCain Maja Laszczewska et al.	Sulfatase-2 from Cancer Associated Fibroblasts: An Environmental Target for Hepatocellular Carcinoma?	2022
Nardeen Eldafashi Dr Rebecca Darlay Dr Ruchi Shukla Misti McCain Robyn Watson et al.	A pdcd1 role in the genetic predisposition to nafld-hcc?	2021
Misti McCain Professor Helen Reeves	Anti-miR-518d-5p overcomes liver tumor cell death resistance through mitochondrial activity	2021
Misti McCain Professor Derek Mann Professor Helen Reeves	Cell-free DNA TAPS provides multimodal information for early cancer detection	2021
Dr Praveen Dhondurao Sudhindar Daniel Wainwright Dr Santu Saha Rachel Howarth Misti McCain et al.	HCV Activates Somatic L1 Retrotransposition—A Potential Hepatocarcinogenesis Pathway	2021
Marco Zaki Dr Ahmed Mahdi Dr Gillian Patman Anna Whitehead Joao Mauricio et al.	Key features of the environment promoting liver cancer in the absence of cirrhosis	2021
Dr Ruchi Shukla Professor Helen Reeves Professor Stuart McPherson Misti McCain Dr Praveen Dhondurao Sudhindar et al.	Hepatitis C virus infection, endogenous retrotransposons activation and cancer risk	2020
Misti McCain Dr Luca Miele Professor Helen Reeves	Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease	2019
Dr Olivier Govaere Misti McCain	The CCR2+ Macrophage Subset Promotes Pathogenic Angiogenesis for Tumor Vascularization in Fibrotic Livers	2019
Misti McCain Professor Helen Reeves	The biomarker potential of Ki67 and pH2AX immunohistochemistry in guiding use of the liver-targeting nucleotide MIV-818 in patients with hepatocellular carcinoma	2018
Misti McCain Dr Luca Miele Dr Paula Iruzubieta Professor Helen Reeves Professor Quentin Anstee et al.	MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals	2017
Dr Paula Iruzubieta Dr Steven Masson Misti McCain Professor Helen Reeves	The mitochondrial negative regulator MCJ is a therapeutic target for acetaminophen-induced liver injury	2017
Dr Sheba Macheka Dr David Jamieson Professor Helen Reeves Misti McCain	The isolation and characterisation of circulating tumour cells from patients with hepatocellular carcinoma	2016